Freebird Partners LP - 10%+ Owner at Ernexa Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
ERNA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Freebird Partners LP since 10 Jan 2025

Holdings reported by Freebird Partners LP for Ernexa Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Convertible Note Shares 783,233 $1,503,337 $1.92 15 Dec 2023 Direct Common Stock, par value $0.005 per share
Common Stock Purchase Warrant 1,991,394 15 Dec 2023 Direct Common Stock, par value $0.005 per share

Transactions reported by Freebird Partners LP for Ernexa Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.